menu
    • menu

    Company profile for Oncotelic Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Oncotelic is an immuno-oncology company dedicated to the development of first in class RNA therapeutics as well as small molecule drugs against cancer and infectious diseases. OT-101, the lead immuno-oncology drug candidate of Oncotelic, is a first-in-class anti-TGF-βRNA therapeutic that exhibited single agent activity in relapsed/refractory cancer patients in clinical trial settings. OT-101 also has activity against SARS-CoV...
    Oncotelic is an immuno-oncology company dedicated to the development of first in class RNA therapeutics as well as small molecule drugs against cancer and infectious diseases. OT-101, the lead immuno-oncology drug candidate of Oncotelic, is a first-in-class anti-TGF-βRNA therapeutic that exhibited single agent activity in relapsed/refractory cancer patients in clinical trial settings. OT-101 also has activity against SARS-CoV-2. Mateon/Oncotelic is seeking to leverage its deep expertise in drug development to improve treatment outcomes and survival of cancer patients with a special emphasis on rare pediatric cancers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Oncotelic TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    29397 Agoura road, Suite 107, Agoura hills CA 91301
    Telephone
    Telephone
    6506357000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.oncotelic.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/oncotelic/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Oncotelic

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Oncotelic Expects Significant Value Increase Post JV Valuation
    Oncotelic Expects Significant Value Increase Post JV Valuation

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194333/0/en/Oncotelic-Therapeutics-Inc-OTCQB-OTLC-Anticipates-Major-Fair-Value-Uptick-Following-New-Independent-JV-Valuation.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share
    Oncotelic Therapeutics Emerges As Leader With Independent JV
    Oncotelic Therapeutics Emerges As Leader With Independent JV

    21 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/21/3192789/0/en/Oncotelic-Therapeutics-Inc-OTCQB-OTLC-Emerging-as-Leader-with-New-Independent-JV-Valuation.html

    GLOBENEWSWIRE
    21 Nov 2025
    Share Share
    Oncotelic Attains $1.7B Pipeline Value In GMP Bio Partnership
    Oncotelic Attains $1.7B Pipeline Value In GMP Bio Partnership

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3191815/0/en/Oncotelic-Achieves-Breakthrough-1-7-Billion-Pipeline-Valuation-Through-GMP-Bio-Joint-Venture.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share
    Investors Await Valuation Signal From Biotech Pipeline Review
    Investors Await Valuation Signal From Biotech Pipeline Review

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3191923/0/en/Remeasuring-Biotech-Pipelines-The-Valuation-Signal-Investors-Have-Been-Waiting-For.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share
    Oncotelic & Sapu Bio Publish Sub-15 Nm Nanoparticles Study
    Oncotelic & Sapu Bio Publish Sub-15 Nm Nanoparticles Study

    11 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/11/3185378/0/en/Oncotelic-Therapeutics-and-Sapu-Bioscience-Announce-Publication-on-Sub-15-nm-Nanoparticles-in-International-Journal-of-Molecular-Sciences.html

    GLOBENEWSWIRE
    11 Nov 2025
    Share Share
    Sapu Nano to Present Sapu003 Data at SABCS 2025
    Sapu Nano to Present Sapu003 Data at SABCS 2025

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177142/0/en/Sapu-Nano-to-present-at-the-2025-San-Antonio-Breast-Cancer-Symposium-SABCS-Highlighting-Sapu003-Deciparticle-Everolimus.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search